Cargando…
Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer
BACKGROUND: Compounded lomustine is used commonly in veterinary patients. However, the potential variability in these formulations is unknown and concern exists that compounded formulations of drugs may differ in potency from Food and Drug Administration (FDA)‐approved products. HYPOTHESIS/OBJECTIVE...
Autores principales: | Burton, J.H., Stanley, S.D., Knych, H.K., Rodriguez, C.O., Skorupski, K.A., Rebhun, R.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913625/ https://www.ncbi.nlm.nih.gov/pubmed/26682700 http://dx.doi.org/10.1111/jvim.13805 |
Ejemplares similares
-
Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015) -
Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin
por: Kopecny, Lucy, et al.
Publicado: (2020) -
Neutropenia in dogs receiving vincristine for treatment of presumptive immune‐mediated thrombocytopenia
por: LaQuaglia, Kathryn A., et al.
Publicado: (2021) -
Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma
por: Story, A.L., et al.
Publicado: (2017) -
Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021)